Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya

BACKGROUND: Severe respiratory syncytial virus (RSV) disease occurs predominantly in children under 6 months of age. There is no licensed RSV vaccine. Protection of young infants could be achieved by a maternal vaccine to boost titres of passively transferred protective antibodies. Data on the level...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyiro, Joyce U., Sande, Charles, Mutunga, Martin, Kiyuka, Patience K., Munywoki, Patrick K., Scott, J. Anthony G., Nokes, D James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376380/
https://www.ncbi.nlm.nih.gov/pubmed/25725445
http://dx.doi.org/10.1016/j.vaccine.2015.02.039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376380/
https://www.ncbi.nlm.nih.gov/pubmed/25725445
http://dx.doi.org/10.1016/j.vaccine.2015.02.039

Ejemplares similares